Location
San Francisco, CA
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
14
Total value ($000)
$251,771
Net value change ($000)
-56,017 (-18.2%)
New positions
2
Sold out positions
1
Turnover %
8.1%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/13/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OBSIDIAN THERAPEUTICS INC 11,813 NEW
BRAVEHEART BIO INC 6,410 NEW
RLYB 361 7.5%
IMNM 234 1.5%
Top Reduces (Value $000, Stocks/ETFs)
MPLT -15,683 -71.6%
BIOA -11,382 -71.1%
EVMN -9,692 -37.8%
TRVI -7,546 -23.2%
AVALYN PHARMACEUTICALS INC -7,132 -22.4%
ARQT -6,530 -19.7%
ZBIO -6,167 -49.5%
OCS -5,398 -25.8%
RXRX -2,186 -100.0%
PCVX -1,754 -2.1%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type